Literature DB >> 9344309

Rehabilitation of Guillain-Barré syndrome.

J M Meythaler1.   

Abstract

Guillain-Barré syndrome (GBS) is the most common cause of acute neuromuscular paralysis in developed countries. GBS is a significant cause of new long-term disability for at least 1,000 persons per year in the United States, and more elsewhere. Given the young age at which GBS sometimes occurs and the relatively long life expectancies following GBS, it is likely that at least 25,000 and perhaps 50,000 persons in the US are experiencing some residual effects of GBS. Approximately 40% of patients who are hospitalized with GBS will require admission to inpatient rehabilitation. For GBS persons necessitating admission to inpatient rehabilitation, the requirement of prior ventilator support most strongly predicts an extended length of stay on inpatient rehabilitation. Other issues that affect rehabilitation are dysautonomia, cranial nerve involvement, and various medical complications associated with GBS. Deafferent pain syndrome is common in the early stages of recovery. Multiple medical complications, including deep venous thrombosis, joint contractures, hypercalcemia of immobilization, and decubitii, may develop in the early stages of recovery and interfere with the rehabilitation program. Anemia is a frequent finding in the first few months of illness but does not appear to interfere with functional recovery. Therapy should not overfatigue the motor unit, which has been associated with paradoxical weakening. Little is known of the long-term implications of the disability caused by GBS. Work similar to that performed for postpolio syndrome and spinal cord injury should be started in the rehabilitation setting.

Entities:  

Mesh:

Year:  1997        PMID: 9344309     DOI: 10.1016/s0003-9993(97)90203-3

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  9 in total

1.  Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome.

Authors:  F Khan; J F Pallant; L Ng; A Bhasker
Journal:  J Neurol       Date:  2010-07-13       Impact factor: 4.849

2.  Long term disability and social status change after Guillain-Barré syndrome.

Authors:  A Bersano; M Carpo; S Allaria; D Franciotta; A Citterio; E Nobile-Orazio
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

3.  Guillain-Barré syndrome: rehabilitation outcome and recent developments.

Authors:  E M Melillo; J M Sethi; V Mohsenin
Journal:  Yale J Biol Med       Date:  1998 Sep-Oct

4.  Pulmonary Involvement in Patients with Guillain-Barré Syndrome in Subacute Phase.

Authors:  Meeka Khanna; Nidhi Rawat; Anupam Gupta; Madhu Nagappa; Arun B Taly; M R Rukmani; T N Sathyaprabha; Partha Haldar
Journal:  J Neurosci Rural Pract       Date:  2017 Jul-Sep

5.  Complications in mechanically ventilated patients of Guillain-Barre syndrome and their prognostic value.

Authors:  Archana Becket Netto; Arun B Taly; Girish B Kulkarni; G S Uma Maheshwara Rao; Shivaji Rao
Journal:  J Neurosci Rural Pract       Date:  2017 Jan-Mar

6.  A patient with Guillain-Barré syndrome and late recovery after 1 year.

Authors:  Konstantinos G Athanasopoulos; Ioannis D Papanastassiou; Ioannis Drinis; Nicholas Groumas; Maria A Gerochristou; Konstantina Petropoulou
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-06-01       Impact factor: 2.041

Review 7.  Psychiatric Sequelae of Guillain-Barré Syndrome: Towards a Multidisciplinary Team Approach.

Authors:  Christopher Hillyar; Anjan Nibber
Journal:  Cureus       Date:  2020-02-19

Review 8.  COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications.

Authors:  Mayanja M Kajumba; Brad J Kolls; Deborah C Koltai; Mark Kaddumukasa; Martin Kaddumukasa; Daniel T Laskowitz
Journal:  SN Compr Clin Med       Date:  2020-11-21

9.  Guillain-Barré syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort.

Authors:  Bhasker Amatya; Fary Khan; Michael Whishaw; Julie F Pallant
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.